Hematopoietic stem cell expansion and generation: the ways to make a breakthrough.
- Author:
Bokyung PARK
1
;
Keon Hee YOO
;
Changsung KIM
Author Information
- Publication Type:Review
- Keywords: HSCT; Stem cell; HLA; Blood generation; HSC expansion
- MeSH: Bone Marrow; Cell Count; Drug Therapy; Heart Diseases; Hematologic Diseases; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells*; Homeostasis; Humans; Metabolism, Inborn Errors; Multiple Myeloma; Neurodegenerative Diseases; Regenerative Medicine; Stem Cells; Tissue Donors
- From:Blood Research 2015;50(4):194-203
- CountryRepublic of Korea
- Language:English
- Abstract: Hematopoietic stem cell transplantation (HSCT) is the first field where human stem cell therapy was successful. Flooding interest on human stem cell therapy to cure previously incurable diseases is largely indebted to HSCT success. Allogeneic HSCT has been an important modality to cure various diseases including hematologic malignancies, various non-malignant hematologic diseases, primary immunodeficiency diseases, and inborn errors of metabolism, while autologous HSCT is generally performed to rescue bone marrow aplasia following high-dose chemotherapy for solid tumors or multiple myeloma. Recently, HSCs are also spotlighted in the field of regenerative medicine for the amelioration of symptoms caused by neurodegenerative diseases, heart diseases, and others. Although the demand for HSCs has been growing, their supply often fails to meet the demand of the patients needing transplant due to a lack of histocompatible donors or a limited cell number. This review focuses on the generation and large-scale expansion of HSCs, which might overcome current limitations in the application of HSCs for clinical use. Furthermore, current proof of concept to replenish hematological homeostasis from non-hematological origin will be covered.
